US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

NBC 7 ‘FOOTBALL NIGHT’ SEGMENT HIGHLIGHTS INTERVIEW WITH MEDICAL MARIJUANA, INC. CEO ABOUT CANNABIS, CONCUSSIONS AND NEW NFLPA PANEL

NBC News Story Quotes Former NFL Player That “There Is a Shift Happening” With the NFL’s Anti-Cannabis Policy, NBC Report Cites New NFLPA CommitteeMedical Marijuana, Inc.  (OTC: MJNA ) is pleased to announce that a new report from NBC 7’s “Football Night”  features an interview with the Company’s CEO Dr. Stuart Titus discussing new research about cannabis and concussions, along with a testimonial from a former NFL player. The NBC News

FORBES FEATURES MEDICAL MARIJUANA, INC. PORTFOLIO COMPANY KANNALIFE IN ARTICLE ON NFL AND CONCUSSION-RELATED DISEASE CTE

Article Explains How Cannabis Could Be the “Holy Grail” of Neurological MedicineMedical Marijuana, Inc.  (OTC: MJNA) announced today that its portfolio company Kannalife Sciences, Inc.  (“Kannalife”) was the focus of a Forbes article  that discussed Kannalife’s role in developing a pharmaceutical treatment for the degenerative brain disorder Chronic Traumatic Encephalopathy (CTE), a

Medical Marijuana, Inc. Announces Its Cannabis Drug Research and Drug Development Pipeline Update

MJNA’s Investments Support Development of New Cannabis-Based Medications and Delivery Methods; Developments Further the Reintroduction of Cannabis Medications GloballyMedical Marijuana, Inc.  (OTC: MJNA) is pleased to announce that the “Company of Firsts” investments are actively fostering cannabis-based drug development and creation of new, innovative medicine delivery methods. These results are intended to expedite the historic reintroduction of cannabis-based medications into U.S. and global healthcare systems. Medical Marijuana, Inc. is placing its

There are no items matching the current filter
There are no more items matching the current filter
Back to top